Pepdox
Studies
Peptides
Calculator
In type 2 diabetes with increased CV risk, tirzepatide reduced HbAvs. glargine at 52 wk. | Pepdox
Home
/
Search
/
PMID 35226523
In type 2 diabetes with increased CV risk, tirzepatide reduced HbAvs. glargine at 52 wk.
Annals of internal medicine
2022
PMID: 35226523
View on PubMed
DOI: 10.7326/J22-0009
Tirzepatide
Abstract
Del Prato S, Kahn SE, Pavo I, et al.Lancet. 2021;398:1811-24. 34672967.
Authors
Singh, Madhusree